Skip to content
AI News HubLIVE
Source content · Analysis pending2 min read

SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity

Summary

arXiv:2609.21165v1 Announce Type: new Abstract: Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce specificity optimization (SpecOpt), a molecular design task that seeks constrained structural modifications to an existing compound that increase its binding preference for an intended target over known off-targets while preserving its structural identity and drug-like properties. To enable systematic evaluation, we construct a ChEMBL-derived benchmark from compound-target interaction data, identifying intended targets through curated drug-mechanism annotations and of…

SourcearXiv AIAuthor: Thao Nguyen, Heng Ji
SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity
Report an error

The correction channel is not available yet. You can copy the article reference below for later.

Correction instructions
Read article

[Submitted on 18 Sep 2026]

Title:SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity

View a PDF of the paper titled SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity, by Thao Nguyen and 1 other authors

View PDF HTML (experimental)

Abstract:Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce specificity optimization (SpecOpt), a molecular design task that seeks constrained structural modifications to an existing compound that increase its binding preference for an intended target over known off-targets while preserving its structural identity and drug-like properties. To enable systematic evaluation, we construct a ChEMBL-derived benchmark from compound-target interaction data, identifying intended targets through curated drug-mechanism annotations and off- targets through measured activities. We then develop an agentic framework that docks each compound against its intended target and off-targets, compares the resulting poses through residue-aware atom-protein contacts, and provides these differential interactions to a large language model to propose targeted structural modifications. Candidates are retained only if they satisfy molecular similarity, ADMET, and target-off-target docking selectivity criteria. On 915 compounds, the agent improves the target- off-target binding gap for 84.8% of compounds, shifting the mean gap from -0.72 to +0.47 kcal/mol while maintaining a mean Tanimoto similarity of 0.72 to the starting compounds. Ablation studies identify residue-specific contact information as the critical optimization signal: replacing residue identities with binary contact indicators eliminates improvement on all 29 ablation compounds. These results establish SpecOpt as a distinct molecular design problem and demonstrate residue-aware differential interactions as an effective signal for improving the specificity of existing compounds.

Subjects:

Artificial Intelligence (cs.AI)

Cite as: arXiv:2609.21165 [cs.AI]

(or arXiv:2609.21165v1 [cs.AI] for this version)

https://doi.org/10.48550/arXiv.2609.21165

arXiv-issued DOI via DataCite (pending registration)

Submission history

From: Thao Nguyen [view email] [v1] Fri, 18 Sep 2026 00:16:35 UTC (703 KB)

Full-text links:

Access Paper:

View a PDF of the paper titled SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity, by Thao Nguyen and 1 other authors

View PDF

HTML (experimental)

TeX Source

view license

Current browse context:

cs.AI

new | recent | 2026-09

Change to browse by:

cs

References & Citations

NASA ADS

Google Scholar

Semantic Scholar

Loading...

Data provided by:

Bibliographic Tools

Bibliographic and Citation Tools

Bibliographic Explorer Toggle

Bibliographic Explorer (What is the Explorer?)

Connected Papers Toggle

Connected Papers (What is Connected Papers?)

Litmaps Toggle

Litmaps (What is Litmaps?)

scite.ai Toggle

scite Smart Citations (What are Smart Citations?)

Code, Data, Media

Code, Data and Media Associated with this Article

alphaXiv Toggle

alphaXiv (What is alphaXiv?)

Links to Code Toggle

CatalyzeX Code Finder for Papers (What is CatalyzeX?)

DagsHub Toggle

DagsHub (What is DagsHub?)

GotitPub Toggle

Gotit.pub (What is GotitPub?)

Huggingface Toggle

Hugging Face (What is Huggingface?)

ScienceCast Toggle

ScienceCast (What is ScienceCast?)

Demos

Demos

Replicate Toggle

Replicate (What is Replicate?)

Spaces Toggle

Hugging Face Spaces (What is Spaces?)

Spaces Toggle

TXYZ.AI (What is TXYZ.AI?)

Related Papers

Recommenders and Search Tools

Link to Influence Flower

Influence Flower (What are Influence Flowers?)

Core recommender toggle

CORE Recommender (What is CORE?)

Author

Venue

Institution

Topic

About arXivLabs

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)

Key points and analysis

Article intelligence

EngineersAdvanced

Key points

  • AI generation is temporarily unavailable; this entry was preserved with deterministic fallback metadata.
  • arXiv:2609.21165v1 Announce Type: new Abstract: Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design…

Highlights and analysis are generated automatically and may contain errors. Check the original source.